The coronary stents market is anticipated to witness significant growth over the coming time period owing to rising prevalence of coronary artery diseases and increasing demand for minimally invasive surgeries.
The coronary stents market is anticipated to witness significant growth over the coming time period owing to rising prevalence of coronary artery diseases and increasing demand for minimally invasive surgeries. Coronary heart disorder is known to be the common heart disorder affecting nearly millions of people across the globe.
At present, emerging companies in the coronary stents market are trying to develop technologically advanced products in order to increase the market penetration. Citing an instance, in October 2020, Medtronic, a renowned medical technology company, reportedly announced that it has received approval from US FDA for its novel dual-antiplatelet therapy labeling with an extended sign for HBR patients embedded with Resolute Onyx™ drug eluting stent. These stents are the very first and the only DES across the US which has been confirmed to be effective and safe, using nearly a 1-month regimen of DAPT. In fact, clinical research studies have shown that Resolute Onyx DES along with its stent design and biocompatible polymer promotes rapid vessel healing.
Global Market Insights, Inc., forecasts that coronary stents market size will be worth $8 billion by 2025.
Increasing adoption of bare-metal stent
With respect to product, the bare metal stent segment will witness tremendous growth over the coming years. In 2018, the segment accounted for approximately $506.5 million. Bare-metal stent is without a coating or covering and were among the first ever stents licensed for use in cardiac arteries. These types of stents decrease the risk of stent thrombosis after undergoing a heart bypass. Rising prevalence of coronary heart disorders across numerous regions of the globe will drive the growth of the segment.
Presence of higher safety standards in hospitals
In terms of end-use, the overall market is categorized into ambulatory surgical centers, cardiac centers, and hospitals. Among these, hospital segment will witness tremendous growth over the coming years. In 2018, the segment held over 40% revenue share. Hospitals which meets the necessary safety standards of PCI can perform stent implantations. Stringent guidelines are followed with optimum safety for such kind of procedures. Consequently, the market would be driven by the presence of high safety standards as well as cost efficiency across government hospitals.
Rising prevalence of cardiovascular diseases across Germany
On the geographical front, coronary stents market in Germany is expected to witness lucrative market growth of nearly 3% over the forthcoming time period. This anticipated growth is ascribed to the rising prevalence of cardiovascular diseases. Meanwhile, increasing number of ambulatory surgical centers across Europe is another factor fueling the business growth. Furthermore, high rate of heart surgeries will also favor the market growth. For example, according to 2016 statistics, nearly 51,000 heart bypass surgeries were conducted across Germany.
To access sample pages of this report titled, “Coronary Stents Market Size By Product (Drug Eluting Stent, Bare Metal Stent, Bioresorbable Vascular Scaffold), By End-Use (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025” in detail along with the table of contents, please click on the link below:
https://www.gminsights.com/request-sample/detail/2966
Today, numerous clinical research studies are being conducted and submitted for regulatory approval to government bodies like the FDA. Citing an instance, in November 2020, 1 year results off the PIONEER III study comparing safety as well as efficacy of the Supreme HT drug-eluting stent to the Promus DP DES demonstrated that it was equal in clinical performance to the industry-leading DES.
The trial results were presented at the AHA (American Heart Association) Scientific Session 2020. The HT-DES is mainly designed for restoring endothelial function after delivery of stent using a combination of a quick sirolimus delivery as well as a bioresorbable PLGA polymer which dissolves after 4-6 weeks and leaves a bare metal stent. The thin strut stent is nearly 80 microns and comprises of a layer of inert eG coating promoting endothelial growth and also aids in avoiding hyperplasia.
Medtronic plc, B. Braun Melsungen AG, Boston Scientific Corporation, Abbott, and Biosensors International Group among many others are some of the key players operating in the coronary stents market.
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com